CNTA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 11.59%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $5,855,386.13

Centessa Pharmaceuticals Insider Trading History Chart

Centessa Pharmaceuticals Share Price & Price History

^$16.74

▼ -0.09 (-0.53%)

As of 11/20/2024 01:00 AM ET

Days: 30 | 90 | 365

Trump’s Sending THIS Crypto Higher on Purpose

From Crypto 101 Media | Ad

Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…

YES, I WANT THE #1 CRYPTO NOW

Centessa Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
10/25/2024	Gregory M Weinhoff	Insider	Sell	11,742	$15.38	$180,591.96	183,266
10/23/2024	Saurabh Saha	CEO	Sell	2,592	$15.32	$39,709.44	630,661
10/21/2024	Saurabh Saha	CEO	Sell	22,205	$15.80	$350,839.00	663,456
9/25/2024	Gregory M Weinhoff	Insider	Sell	16,619	$15.69	$260,752.11	206,750
9/20/2024	Saurabh Saha	CEO	Sell	55,000	$16.53	$909,150.00	721,924
9/10/2024	Saurabh Saha	CEO	Sell	175,000	$16.52	$2,891,000.00	776,924
9/9/2024	Gregory M Weinhoff	Insider	Sell	25,000	$15.00	$375,000.00	223,369
8/22/2024	Gregory M Weinhoff	Insider	Sell	12,198	$12.17	$148,449.66	241,171
8/22/2024	Saurabh Saha	CEO	Sell	506	$12.23	$6,188.38	823,575
8/20/2024	Saurabh Saha	CEO	Sell	4,169	$12.32	$51,362.08	827,755
3/25/2024	Karen M Anderson	Insider	Sell	51,160	$11.88	$607,780.80	71,525
2/1/2024	Harris Rotman	SVP	Sell	4,267	$8.10	$34,562.70	62,625
9/20/2023	Harris Rotman	SVP	Sell	37,484	$6.29	$235,774.36	33,500
6/1/2023	Antoine Yver	EVP	Sell	6,500	$4.45	$28,925.00	783,066
5/24/2023	Tia L. Bush	Insider	Sell	8,000	$4.48	$35,840.00	157,102
5/1/2023	Antoine Yver	EVP	Sell	6,800	$4.42	$30,056.00	789,566
1/4/2023	Antoine Yver	EVP	Sell	6,970	$3.18	$22,164.60	751,913
12/1/2022	Antoine Yver	EVP	Sell	9,400	$3.91	$36,754.00	761,151
11/1/2022	Antoine Yver	EVP	Sell	9,700	$4.03	$39,091.00	765,059
10/3/2022	Antoine Yver	EVP	Sell	12,524	$3.92	$49,094.08	774,759
10/3/2022	David M Chao	Insider	Sell	4,167	$3.95	$16,459.65	222,932
10/3/2022	Gregory M Weinhoff	CFO	Sell	4,901	$3.95	$19,358.95	231,099
10/3/2022	Iqbal J Hussain	General Counsel	Sell	4,563	$3.95	$18,023.85	154,712
10/3/2022	Thomas Templeman	CTO	Sell	2,455	$3.95	$9,697.25	135,792
9/30/2022	Antoine Yver	EVP	Sell	2,468	$4.07	$10,044.76	787,283
9/30/2022	David M Chao	Insider	Sell	3,401	$4.07	$13,842.07	227,099
9/30/2022	Gregory M Weinhoff	CFO	Sell	4,000	$4.07	$16,280.00	236,000
9/30/2022	Iqbal J Hussain	General Counsel	Sell	3,725	$4.07	$15,160.75	159,275
9/30/2022	Thomas Templeman	CTO	Sell	2,003	$4.07	$8,152.21	138,247
8/1/2022	Antoine Yver	EVP	Sell	10,423	$4.45	$46,382.35	800,174
7/18/2022	Antoine Yver	EVP	Sell	20,000	$4.87	$97,400.00	810,597
7/1/2022	Antoine Yver	EVP	Sell	9,100	$5.03	$45,773.00	730,597
6/24/2022	Saurabh Saha	CEO	Buy	10,000	$4.63	$46,300.00	38,000
6/17/2022	Antoine Yver	EVP	Sell	9,200	$4.68	$43,056.00	739,697
5/17/2022	Antoine Yver	EVP	Sell	20,222	$5.42	$109,603.24	813,675
2/2/2022	Saurabh Saha	CEO	Buy	5,000	$9.74	$48,700.00
1/28/2022	David J. Grainger	Insider	Buy	27,500	$9.05	$248,875.00
12/2/2021	Medicxi Ventures Management (J	Major Shareholder	Buy	34,326	$12.82	$440,059.32
12/1/2021	Francesco De Rubertis	Director	Buy	60,304	$12.62	$761,036.48
11/30/2021	Medicxi Ventures Management (J	Major Shareholder	Buy	36,847	$11.62	$428,162.14
11/29/2021	Francesco De Rubertis	Director	Buy	56,706	$11.70	$663,460.20
11/26/2021	Francesco De Rubertis	Director	Buy	11,817	$11.34	$134,004.78

From Porter & Company | Ad

The AI boom is just getting started. And the real wealth has still to be made…

You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for Centessa Pharmaceuticals (NASDAQ:CNTA)

82.01% of Centessa Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Centessa Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	56,597	$0.91M	0.0%	+68.7%	0.050%
11/15/2024	XTX Topco Ltd	10,174	$0.16M	0.0%	-37.9%	0.009%
11/15/2024	Jane Street Group LLC	177,260	$2.83M	0.0%	N/A	0.156%
11/15/2024	Wellington Management Group LLP	100,613	$1.61M	0.0%	N/A	0.089%
11/15/2024	State Street Corp	48,592	$0.78M	0.0%	N/A	0.043%
11/15/2024	RTW Investments LP	50,000	$0.80M	0.0%	N/A	0.044%
11/15/2024	Point72 Asset Management L.P.	2,715,663	$43.42M	0.1%	+54.1%	2.397%
11/15/2024	Janus Henderson Group PLC	1,294,864	$20.70M	0.0%	N/A	1.143%
11/15/2024	HighVista Strategies LLC	46,116	$0.74M	0.3%	N/A	0.041%
11/15/2024	Baker BROS. Advisors LP	1,227,178	$19.62M	0.2%	+123.4%	1.083%
11/14/2024	PFM Health Sciences LP	269,158	$4.30M	0.2%	-57.7%	0.238%
11/14/2024	Fred Alger Management LLC	177,553	$2.84M	0.0%	+1,515.1%	0.157%
11/14/2024	Walleye Capital LLC	11,721	$0.19M	0.0%	N/A	0.010%
11/14/2024	Suvretta Capital Management LLC	70,000	$1.12M	0.0%	N/A	0.062%
11/14/2024	Ally Bridge Group NY LLC	309,614	$4.95M	2.7%	N/A	0.273%
11/13/2024	FMR LLC	2,916,494	$46.64M	0.0%	+4.6%	2.574%
11/13/2024	The Manufacturers Life Insurance Company	264,969	$4.24M	0.0%	+88.1%	0.234%
11/5/2024	GSA Capital Partners LLP	93,658	$1.50M	0.1%	+66.1%	0.083%
11/1/2024	Atria Investments Inc	17,134	$0.27M	0.0%	+7.0%	0.015%
10/25/2024	China Universal Asset Management Co. Ltd.	13,593	$0.22M	0.0%	+99.7%	0.014%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,556	$40K	0.0%	+47.7%	0.003%
10/17/2024	Harbour Capital Advisors LLC	16,675	$0.26M	0.1%	N/A	0.017%
10/7/2024	GAMMA Investing LLC	2,972	$48K	0.0%	+103.1%	0.003%
9/16/2024	Cubist Systematic Strategies LLC	26,073	$0.24M	0.0%	-64.1%	0.026%
8/20/2024	Nantahala Capital Management LLC	450,000	$4.06M	0.2%	N/A	0.448%
8/19/2024	Point72 Asset Management L.P.	1,762,004	$15.91M	0.0%	-22.0%	1.754%
8/16/2024	Perceptive Advisors LLC	3,933,307	$35.52M	0.8%	+27.6%	3.914%
8/16/2024	Quarry LP	9,608	$87K	0.0%	+47.8%	0.010%
8/16/2024	Driehaus Capital Management LLC	2,092,011	$18.89M	0.2%	+89.5%	2.082%
8/15/2024	The Manufacturers Life Insurance Company	140,894	$1.27M	0.0%	+30.4%	0.140%
8/15/2024	Affinity Asset Advisors LLC	1,135,702	$10.26M	1.2%	+36.7%	1.130%
8/14/2024	Fred Alger Management LLC	10,993	$99K	0.0%	N/A	0.011%
8/14/2024	Sandia Investment Management LP	10,000	$90K	0.1%	N/A	0.010%
8/14/2024	Cubist Systematic Strategies LLC	26,073	$0.24M	0.0%	-64.1%	0.026%
8/14/2024	First Light Asset Management LLC	4,780,560	$43.17M	3.8%	+59.2%	4.758%
8/14/2024	Marshall Wace LLP	224,948	$2.03M	0.0%	-2.9%	0.224%
8/14/2024	Farallon Capital Management LLC	1,996,000	$18.02M	0.1%	+438.0%	1.986%
8/12/2024	XTX Topco Ltd	16,385	$0.15M	0.0%	N/A	0.016%
8/9/2024	Renaissance Technologies LLC	173,700	$1.57M	0.0%	-20.6%	0.173%
8/8/2024	American Century Companies Inc.	935,151	$8.44M	0.0%	+1.3%	0.931%
8/3/2024	TD Asset Management Inc	321,168	$2.90M	0.0%	+40.5%	0.320%
7/29/2024	HighMark Wealth Management LLC	93,000	$0.84M	0.5%	N/A	0.093%
5/30/2024	Lynx1 Capital Management LP	17,400	$0.20M	0.1%	N/A	0.017%
5/24/2024	Farallon Capital Management LLC	371,000	$4.19M	0.0%	N/A	0.369%
5/17/2024	Artal Group S.A.	1,412,500	$15.96M	0.4%	+39.5%	1.250%
5/15/2024	First Light Asset Management LLC	3,002,045	$33.92M	2.6%	N/A	2.980%
5/15/2024	Price T Rowe Associates Inc. MD	2,958,079	$33.43M	0.0%	+16.5%	2.936%
5/15/2024	Affinity Asset Advisors LLC	830,546	$9.39M	1.2%	+4.4%	0.824%
5/14/2024	EntryPoint Capital LLC	9,636	$0.11M	0.1%	N/A	0.010%
5/14/2024	Platinum Investment Management Ltd.	485,174	$5.48M	0.2%	+27.3%	0.482%
5/10/2024	Acadian Asset Management LLC	29,409	$0.33M	0.0%	N/A	0.029%
4/29/2024	China Universal Asset Management Co. Ltd.	10,817	$0.12M	0.0%	+69.2%	0.011%
2/20/2024	Quarry LP	6,000	$48K	0.0%	N/A	0.006%
2/15/2024	Octagon Capital Advisors LP	2,060,100	$16.40M	2.6%	+333.2%	2.110%
2/15/2024	BVF Inc. IL	8,774,570	$69.85M	1.8%	-3.6%	8.988%
2/14/2024	Kynam Capital Management LP	442,704	$3.52M	0.4%	-39.4%	0.453%
2/14/2024	Platinum Investment Management Ltd.	381,083	$3.03M	0.1%	+12.9%	0.390%
2/13/2024	Affinity Asset Advisors LLC	795,729	$6.33M	1.2%	-21.8%	0.815%
2/9/2024	Franklin Resources Inc.	1,115,817	$8.88M	0.0%	+34.1%	1.143%
2/9/2024	Trexquant Investment LP	14,354	$0.11M	0.0%	N/A	0.015%
2/7/2024	Jump Financial LLC	14,300	$0.11M	0.0%	N/A	0.015%
1/24/2024	China Universal Asset Management Co. Ltd.	6,394	$51K	0.0%	+371.2%	0.007%
11/15/2023	Kynam Capital Management LP	730,472	$4.73M	0.8%	+0.2%	0.768%
11/15/2023	Acuta Capital Partners LLC	323,349	$2.09M	1.4%	N/A	0.340%
11/15/2023	Adage Capital Partners GP L.L.C.	2,830,500	$18.31M	0.0%	+25.8%	2.974%
11/15/2023	Affinity Asset Advisors LLC	1,018,091	$6.59M	1.9%	+13.0%	1.045%
11/13/2023	Rathbones Group PLC	31,300	$0.20M	0.0%	N/A	0.032%
11/3/2023	Platinum Investment Management Ltd.	337,544	$2.18M	0.1%	+96.7%	0.347%
10/27/2023	TD Asset Management Inc	186,310	$1.21M	0.0%	+127.1%	0.191%
8/21/2023	Affinity Asset Advisors LLC	900,723	$5.58M	1.9%	+31.7%	0.947%
8/11/2023	Platinum Investment Management Ltd.	171,625	$1.06M	0.0%	N/A	0.180%
8/3/2023	Tanager Wealth Management LLP	696,096	$4.31M	0.9%	-5.6%	0.728%
5/16/2023	BVF Inc. IL	9,423,215	$36.28M	1.3%	+36.7%	9.961%
5/15/2023	Affinity Asset Advisors LLC	684,127	$2.63M	0.9%	+48.6%	0.723%
5/15/2023	EcoR1 Capital LLC	5,618,779	$21.63M	0.7%	+7.4%	5.939%
5/15/2023	Sio Capital Management LLC	347,869	$1.34M	0.7%	N/A	0.368%
4/18/2023	Tanager Wealth Management LLP	737,059	$2.84M	0.7%	-60.8%	0.779%
2/14/2023	EcoR1 Capital LLC	5,232,279	$16.22M	0.5%	+61.7%	5.531%
1/27/2023	Tanager Wealth Management LLP	1,878,383	$5.82M	1.6%	N/A	1.986%
11/15/2022	Kynam Capital Management LP	731,521	$2.94M	0.6%	-3.5%	0.775%
11/15/2022	EcoR1 Capital LLC	3,236,352	$13.01M	0.4%	+1,007.1%	3.431%
11/15/2022	Ensign Peak Advisors Inc	248,228	$1M	0.0%	+101.7%	0.263%
11/14/2022	Cormorant Asset Management LP	1,972,728	$7.93M	0.6%	-32.6%	2.091%
11/14/2022	Point72 Asset Management L.P.	117,800	$0.47M	0.0%	-11.8%	0.125%
8/16/2022	Woodline Partners LP	1,314,652	$6.40M	0.1%	+48.9%	1.398%
8/12/2022	Ensign Peak Advisors Inc	123,071	$0.60M	0.0%	-61.1%	0.131%
8/12/2022	Franklin Resources Inc.	832,932	$4.06M	0.0%	+35.0%	0.886%
8/11/2022	Alps Advisors Inc.	55,785	$0.27M	0.0%	N/A	0.059%
8/4/2022	TD Asset Management Inc.	82,055	$0.40M	0.0%	+146.8%	0.087%
7/26/2022	Mirae Asset Global Investments Co. Ltd.	57,342	$0.70M	0.0%	N/A	0.061%
5/13/2022	Kynam Capital Management LP	669,100	$6M	1.9%	+179.9%	0.712%
5/4/2022	OUP Management Co. LLC	2,937,615	$26.35M	20.1%	+25.4%	3.124%
2/19/2022	Woodline Partners LP	801,136	$9.02M	0.1%	-9.3%	0.891%
2/15/2022	Samsara BioCapital LLC	1,459,693	$16.44M	3.2%	-5.1%	1.624%
2/14/2022	Virtus ETF Advisers LLC	14,798	$0.17M	0.1%	N/A	0.016%
2/14/2022	Boxer Capital LLC	1,251,137	$14.09M	0.5%	-6.2%	1.392%
2/14/2022	Point72 Asset Management L.P.	1,097,908	$12.36M	0.0%	+263.3%	1.221%
2/14/2022	Deep Track Capital LP	400,000	$4.50M	0.3%	N/A	0.445%
2/14/2022	Affinity Asset Advisors LLC	419,144	$4.72M	1.7%	+106.3%	0.466%
2/11/2022	Ensign Peak Advisors Inc	343,292	$3.87M	0.0%	+19.9%	0.382%

Data available starting January 2016

Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines for patients. Its products pipeline includes SerpinPC, an activated protein C inhibitor for the treatment of hemophilia A and B; and ORX750, an orally administered OX2R agonist for the treatment of narcolepsy and other sleep disorders. The company also develops LB101, a PD-L1xCD47 LockBody, a bi-specific monoclonal antibody for solid tumors, which is designed to selectively drive potent CD47 and CD3 effector function activity while avoiding systemic toxicity; and OX2R Agonists compounds are currently in development for the treatment of narcolepsy. In addition, its products pipeline comprises ORX750, an orally administered selective orexin receptor-2 (OX2R) agonist for the treatment of narcolepsy and other sleep disorders; and earlier-stage preclinical assets and discovery-stage programs. Centessa Pharmaceuticals plc was incorporated in 2020 and is headquartered in Altrincham, the United Kingdom.

Today's Range

Now: $16.74

$16.46

$17.35

50 Day Range

MA: $16.03

$15.04

$18.08

52 Week Range

Now: $16.74

$5.58

$18.74

Volume

622,655 shs

Average Volume

509,086 shs

Market Capitalization

$1.90 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.47

Who are the company insiders with the largest holdings of Centessa Pharmaceuticals?: Centessa Pharmaceuticals' top insider shareholders include:
Saurabh Saha (CEO)
Antoine Yver (EVP)
Gregory M Weinhoff (Insider)
Tia L Bush (Insider)
Karen M Anderson (Insider)
Harris Rotman (SVP)
Learn More about top insider investors at Centessa Pharmaceuticals.
Who are the major institutional investors of Centessa Pharmaceuticals?: Centessa Pharmaceuticals' top institutional investors include:
FMR LLC — 2.57%
Point72 Asset Management L.P. — 2.40%
Janus Henderson Group PLC — 1.14%
Baker BROS. Advisors LP — 1.08%
Ally Bridge Group NY LLC — 0.27%
PFM Health Sciences LP — 0.24%
Learn More about top institutional investors of Centessa Pharmaceuticals stock.
Which institutional investors are selling Centessa Pharmaceuticals stock?: Within the previous quarter, CNTA stock was sold by these institutional investors:
PFM Health Sciences LP
XTX Topco Ltd
During the previous year, company insiders that have sold Centessa Pharmaceuticals company stock include:
Saurabh Saha (CEO)
Antoine Yver (EVP)
Gregory M Weinhoff (Insider)
Tia L Bush (Insider)
Learn More investors selling Centessa Pharmaceuticals stock.
Which institutional investors are buying Centessa Pharmaceuticals stock?: Within the previous quarter, CNTA stock was purchased by institutional investors including:
Janus Henderson Group PLC
Point72 Asset Management L.P.
Baker BROS. Advisors LP
Ally Bridge Group NY LLC
Jane Street Group LLC
Fred Alger Management LLC
FMR LLC
The Manufacturers Life Insurance Company